StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Monday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

T2 Biosystems stock opened at $0.13 on Monday. T2 Biosystems has a 1 year low of $0.06 and a 1 year high of $6.80. The firm has a 50-day moving average of $0.22 and a two-hundred day moving average of $0.96.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.